Alkermes (ALKS) Non Operating Income (2010 - 2026)
Alkermes (ALKS) reported Non Operating Income of -$13.6 million for Q1 2026, down 216.66% year-over-year from $11.7 million in Q1 2025, and down 700.35% quarter-over-quarter from $2.3 million in Q4 2025.
Alkermes (ALKS) Non Operating Income (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Non Operating Income data on file, last reported at -$13.6 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$13.6 million, down 216.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $208000.0 (down 99.53% YoY), and the FY2025 annual result was $37.5 million, up 62.21% from the prior year.
- Non Operating Income eased to -$13.6 million in Q1 2026 per ALKS's latest filing, from $2.3 million in the prior quarter.
- Over five years, Non Operating Income peaked at $20.3 million in Q4 2024 and troughed at -$18.4 million in Q1 2022.
- A 5-year average of $1.6 million and a median of $1.8 million in 2022 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income tumbled 4585.24% in 2022, then soared 3573.83% in 2024.
- A 5-year view of Non Operating Income shows it stood at -$1.9 million in 2022, then jumped by 298.22% to $3.7 million in 2023, then soared by 451.45% to $20.3 million in 2024, then sank by 88.81% to $2.3 million in 2025, then sank by 700.35% to -$13.6 million in 2026.
- Business Quant data shows ALKS's Non Operating Income at -$13.6 million in Q1 2026, $2.3 million in Q4 2025, and -$280000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | -4.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.65 Mn |
| Dec 31, 2025 | 2.27 Mn |
| Sep 30, 2025 | -280,000.00 |
| Jun 30, 2025 | 11.86 Mn |
| Mar 31, 2025 | 11.70 Mn |
| Dec 31, 2024 | 20.32 Mn |
| Sep 30, 2024 | 5.47 Mn |
| Jun 30, 2024 | 6.84 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Dec 31, 2023 | 3.69 Mn |
| Sep 30, 2023 | 149,000.00 |
| Jun 30, 2023 | 560,000.00 |
| Mar 31, 2023 | -361,000.00 |
| Dec 31, 2022 | -1.86 Mn |
| Sep 30, 2022 | -6.73 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | -18.41 Mn |
| Dec 31, 2021 | -2.16 Mn |
| Sep 30, 2021 | 288,000.00 |
| Jun 30, 2021 | -222,000.00 |